General information

annual Charcot Meeting
More information Here

Have a look at the Program

Information on the MSGF

Venue

Grand Hotel Dino
Corso Giuseppe Garibaldi, 20
28831 Baveno (VB), Italy
T: +39 03 23 92 22 01
W: https://dino.zaccherahotels.com/en/

Practical information

Contact

Anne-Sophie Squiban : +33 674523709 – annesophie.squiban@tmacademy.org

Christian Schoen: +33 685106059 – christian.schoen@tmacademy.org

Don’t miss it
Wednesday 29 November, 2017
18:30 – 19:15      Satellite Symposium Actelion
Treating MS beyond monotherapy
Actelion-sponsored Satellite Symposium chaired by prof P. Vermersch, presented by prof G. Giovannoni, and prof M.P. Sormani.
Open to all.

Thursday 30 November, 2017
10:35 – 11:35   Satellite Symposium EXCEMED – Excellence in Medical Education Multiple Sclerosis: today’s choices for tomorrow’s reality
Introduction and welcome
Giancarlo Comi
Immunological modes of action and clinical efficacy of emerging MS treatments
Heinz Wiendl
High efficacy treatments in the management of patients
Klaus Schmierer
Tackling clinical decision making and conclusions
Gavin Giovannoni

11:45 – 12:45   Satellite Symposium Merck
Cladribine Tablets in MS: providing durable efficacy and a reduced monitoring burden through a unique MoA
Welcome and objectives
Hans-Peter Hartung
Cladribine Tablets: an innovative treatment that provides durable efficacy in MS
Oscar Fernandez
Cladribine Tablets: Safety and tolerability profile and implication for monitoring
Antonio Uccelli
Q&A – Panel discussion
Wrap up and Close
Hans-Peter Hartung

18:15 – 19:15   Satellite Symposium Sanofi Genzyme
Evolving landscapes in MS research and clinical practice – From traditional to novel measures
Welcome and Introduction
Nicola De Stefano
Novel clinical measures to assess MS-related parameters and treatment efficacy
Ralf Linker
New insights into patient-reported outcomes in MS
Iris-Katharina Penner
Q&A

Friday 1 December 2017
18:15 – 19:15   Satellite Symposium Celgene – The evolution of MS Treatment: S1P Modulators; reviewing ongoing clinical development programs
Welcome and Introductions
Maria Pia Amato
Exploring the Underlying Mechanism of Disease
Ludwig Kappos
S1P Modulators and Phase 2 & 3 Trials
Hans-Peter Hartung
Meeting Close
Maria Pia Amato